Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Health and Human Services
Preview Health runs a Health and Human Services operation from Sydney. It is privately held, and its site is preview.health. It holds one address on record, all in Australia. Headcount on record is 6. Its work is tagged biotech, ai and medtech. One Australian registration (ABN) is a confirmed match. The latest round on record is Pre seed at US$6.5K. The record links six similar brands, most of them in Biotechnology Research.
ABN13673075842
| PREVIEW HEALTH PTY LTD | ABN 13673075842 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Finding the hidden changes in your brain so you can understand what’s really going on.
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
| Rounds | 1 |
|---|---|
| Axis | 2024 to 2027 |
| Pre seed · 1 Sep 2024 | US$ 6.5K |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
One New South Wales entity on the ABR: PREVIEW HEALTH PTY LTD (ABN 13 673 075 842), high confidence.
6 counted staff profiles at January 2026, inside the self-reported 2–10 band.
One address on record, Australia only. Primary: Sydney.
One round. Latest 1 September 2024: pre seed, US$6,500.
Four tags on the brand's own list, among them biotech, ai and medtech.
Six peer profiles on record: Australian Fulbright Alumni Association (AFAA) and EosGene Therapeutics.